Shared decision making underpins good health care

17 June 2021 - Shared decision making between service users and health care professionals is an integral part of health care, ...

Read more →

Health care funding decisions and real world benefits: reducing bias by matching untreated patients

14 June 2021 - Governments and health insurers often make funding decisions based on health gains from randomised controlled trials.  ...

Read more →

How the patient voice is becoming vital for drug approval

14 June 2021 - Rebecca Sanders from Lipodystrophy UK tells us how the patient voice helped convince NICE to approve a ...

Read more →

Stop blaming PHARMAC - we'd be worse off without it

10 June 2021 - Penny Tucker is concerned that there are “miracle drugs and biologics that have transformed many conditions ...

Read more →

AMA and Australian Government agree to strengthening the MBS review process and informed financial consent

8 June 2021 - The Australian Government and the Australian Medical Association have reached agreement to work together to co-design the ...

Read more →

'Anticancer drug should extend life for 22 months to get insurance benefits'

27 May 2021 - A research team at National Cancer Center has found that the public believes that for an ...

Read more →

PHARMAC to work with others to improve communication

21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...

Read more →

Quality, access, and the use of real world data by payers: where are we now? Where do we want to be in the future?

15 May 2021 - One of the biggest challenges payers face today is determining the value of innovative therapies in diseases ...

Read more →

Uncertain effect and high prices of precision medicine are challenging

3 May 2021 - In a report to the government, the Swedish Dental and Pharmaceutical Benefits Agency, TLV, describes the most ...

Read more →

Andrew Little not pleased with Children's Commissioner comments on potential PHARMAC move

4 May 2021 - Heath Minister Andrew Little says he expects better of the Children's Commissioner after he described a potential ...

Read more →

Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review

26 April 2021 - The objective was to describe the type and level of ethical integration in published health technology assessment ...

Read more →

Do existing real world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal

28 April 2021 - Technological and computational advancements offer new tools for the collection and analysis of real world data.  ...

Read more →

NICE signs up to join the GetReal Institute

28 April 2021 -NICE’s ambition complements the GetReal Institute’s core mission to facilitate the adoption and implementation of real-world evidence ...

Read more →

Medicare Benefits Schedule Electrocardiogram Review Committee – appointment of Committee Members

15 April 2021 - The Medicare Benefits Schedule Review Committee was established in March 2021 to review electrocardiogram items introduced on ...

Read more →

Prevalence of immature survival data for anti-cancer drugs presented to the National Institute for Health and Care Excellence and impact on decision-making

12 April 2021 - This research aims to explore how often NICE uses immature overall survival data to inform reimbursement ...

Read more →